BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BTX-A51 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BTX-A51\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06414434-3032@assetmemo.bio
DTSTAMP:20261121T005356Z
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270116
SUMMARY:BTX-A51: Phase 1 readout est. (NCT06414434)
DESCRIPTION:BTX-A51\, phase 1.\nStudy: BTX-A51 in Patients With Liposarcoma
  or CIC-rearranged Sarcoma\nEstimated primary completion: 15 January 2027.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/btx-a51#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT06414434
URL:https://assetmemo.bio/drug/btx-a51#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
